Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Augmentation of Cognitive Training in Pediatric TBI
NCT02312635Phase 1Unknown
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2012
- Primary completion
- Sep 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in traumatic brain injury (TBI) comparing Cogmed + D-cycloserine with Cogmed + Placebo (2 arms). Primary endpoint: Cogmed Working Memory Training Program Improvement Index at 6 weeks. Status: unknown.
02
Drugs
d-cycloserine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02312635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312635.